(PharmaNewsWire.Com, June 06, 2018 ) According to Publisher research report, Global Coronary Stents (Bare Metal,Drug-Eluting, Bioresorable) Market: Analysis By Segment, By Region, By Country(2016-2021) - (By Segment - Bare Metal stents (BMS), Drug-Eluting Stents (DES), Bioresorbable Stents; By Region - North America, Europe, APAC, ROW; By Country - USA, Canada, UK,Germany, India, Japan, China, Brazil, UAE), Global Coronary Stents market is projected to exhibit a CAGR of over ~3.05%during 2016 - 2021. On the basis of market segment, Global Coronary Stents Markethas been segmented as Bare Metal stents (BMS), Drug-ElutingStents (DES) and Bioresorbable Stents; analysed by Regions-North America, Europe, APAC, ROW and by Country - USA, Canada, UK,Germany, India, Japan, China, Brazil, UAE.
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research,the report aims to present the analysis of global coronary stent market on the basis of Segments (Bare Metal stents or BMS, Drug-Eluting Stents or DES and Bioresorbable Stents), By Region (North America, Europe, APAC and ROW)and By Country (USA, Canada,UK, Germany, India, Japan, China, Brazil, UAE). Rising development of bioresorbable stents combined with the growing awareness towards cardiovascular risks in developing countries has resulted in the growth of coronary stents market. Cardiovascular diseases are witnessing growth on account of the rise in the lifestyle related diseases including obesity,diabetes, hypertension etc.
Among the types of coronary stents, market is expected to be driven by bioresorbable stents, mainly in the polylactic acid material. However, drug eluting stents will continue to generate major revenue while bare metal stents will further continue to decline.
While developed regions will continue to dominate the market in terms of revenue, emerging nations are expected to respond to the market optimistically due to the developing healthcare infrastructure and rising focus on healthcare among the growing middle class population.
Global Coronary Stents Market is forecasted to grow at a CAGR of 3.05% during 2016 - 2021F, on account of rising incidences of cardiovascular diseases globally leading to growing number of stent procedures.
The North American region remains the major market followed by Europe in the actual period, while APAC and ROW will witness strong growth in the forecast period.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
